Skip to main content

Table 10 Included studies—surgical treatment of peri-implantitis: adjunctive resective therapy

From: Efficacy of alternative or adjunctive measures to conventional treatment of peri-implant mucositis and peri-implantitis: a systematic review and meta-analysis

Publication

Design

Population

Case definition

Period

Test

Control

Mean (SD) outcome

Romeo et al. [42, 57]

RCT, parallel

17 patients

Suppuration or sulcus bleeding, PD >4 mm horizontal peri-implant translucency

36 months systemic antibiotic medication (Amoxicillin for 8 days)

Full mouth disinfection/mechanical debridement + resective therapy (apical re-positioned flap + bone re-contouring) + decontamination using metronidazole + tetracycline hydrochloride (3 min) + implantoplasty using diamond and arkansas burs/silicone polishers

Full mouth disinfection/mechanical debridement + resective therapy (apical re-positioned flap + bone re-contouring) + decontamination using metronidazole + tetracycline hydrochloride (3 min)

Test

  

22 implants rough surfaces

    

BOP: 2.83 (0.47) (BL) to 0.5 (0.69) (24 monthsa, implant level)

PD: 5.79 (1.69) (BL) to 3.58 (1.06) mm (24 monthsa, implant level)

       

MBL: 0.0–0.01 mm (36 months, implant level)

       

Control

       

BOP: 2.86 (0.35) (BL) to 2.33 (0.74) (24 monthsa, implant level)

       

PD: 6.52 (1.62) (BL) to 5.5 (1.47) mm (24 monthsa, implant level)

       

MBL: 1.44–1.54 mm (36 months, implant level)

  1. BL baseline, BOP bleeding on probing, MBL marginal bone loss, PD probing pocket depth, RCT randomized controlled clinical study
  2. aAll patients of the control group were discontinued from the study due to persistent clinical signs of inflammation